{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:57:29Z","timestamp":1790366249919,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:00:00Z","timestamp":1547164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81822002"],"award-info":[{"award-number":["81822002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91439203"],"award-info":[{"award-number":["91439203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630010"],"award-info":[{"award-number":["81630010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81790624"],"award-info":[{"award-number":["81790624"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771264"],"award-info":[{"award-number":["31771264"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31800973"],"award-info":[{"award-number":["31800973"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700262"],"award-info":[{"award-number":["81700262"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12933-019-0811-7","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T03:55:15Z","timestamp":1547178915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["MiR-30c\/PGC-1\u03b2 protects against diabetic cardiomyopathy via PPAR\u03b1"],"prefix":"10.1186","volume":"18","author":[{"given":"Zhongwei","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanru","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengwen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"issue":"10027","key":"811_CR1","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","volume":"387","author":"Collaboration NCDRF","year":"2016","unstructured":"Collaboration NCDRF. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513\u201330.","journal-title":"Lancet"},{"issue":"4","key":"811_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229\u201334.","journal-title":"N Engl J Med"},{"issue":"2","key":"811_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/HJH.0b013e3283331169","volume":"28","author":"G Simone de","year":"2010","unstructured":"de Simone G, Devereux RB, Chinali M, Lee ET, Galloway JM, Barac A, Panza JA, Howard BV. Diabetes and incident heart failure in hypertensive and normotensive participants of the strong heart study. J Hypertens. 2010;28(2):353\u201360.","journal-title":"J Hypertens"},{"issue":"6","key":"811_CR4","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30(6):595\u2013602.","journal-title":"Am J Cardiol"},{"issue":"4","key":"811_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/(SICI)1096-9136(199604)13:4<321::AID-DIA3>3.0.CO;2-7","volume":"13","author":"P Bonito Di","year":"1996","unstructured":"Di Bonito P, Cuomo S, Moio N, Sibilio G, Sabatini D, Quattrin S, Capaldo B. Diastolic dysfunction in patients with non-insulin-dependent diabetes mellitus of short duration. Diabet Med. 1996;13(4):321\u20134.","journal-title":"Diabet Med"},{"issue":"39","key":"811_CR6","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"L Ryden","year":"2013","unstructured":"Task Force M, Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European society of cardiology (ESC) and developed in collaboration with the European association for the study of diabetes (EASD). Eur Heart J. 2013;34(39):3035\u201387.","journal-title":"Eur Heart J"},{"issue":"2","key":"811_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","volume":"18","author":"T Miki","year":"2013","unstructured":"Miki T, Yuda S, Kouzu H, Miura T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev. 2013;18(2):149\u201366.","journal-title":"Heart Fail Rev"},{"issue":"19","key":"811_CR8","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1161\/01.CIR.101.19.2271","volume":"101","author":"RB Devereux","year":"2000","unstructured":"Devereux RB, Roman MJ, Paranicas M, O\u2019Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Howard BV. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation. 2000;101(19):2271\u20136.","journal-title":"Circulation"},{"key":"811_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12933-015-0173-8","volume":"14","author":"J Fuentes-Antras","year":"2015","unstructured":"Fuentes-Antras J, Picatoste B, Ramirez E, Egido J, Tunon J, Lorenzo O. Targeting metabolic disturbance in the diabetic heart. Cardiovasc Diabetol. 2015;14:17.","journal-title":"Cardiovasc Diabetol"},{"issue":"17","key":"811_CR10","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1089\/ars.2015.6305","volume":"22","author":"MM Sung","year":"2015","unstructured":"Sung MM, Hamza SM, Dyck JR. Myocardial metabolism in diabetic cardiomyopathy: potential therapeutic targets. Antioxid Redox Signal. 2015;22(17):1606\u201330.","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"811_CR11","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/cvr\/cvx018","volume":"113","author":"CR Chong","year":"2017","unstructured":"Chong CR, Clarke K, Levelt E. Metabolic remodeling in diabetic cardiomyopathy. Cardiovasc Res. 2017;113(4):422\u201330.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"811_CR12","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","volume":"85","author":"WC Stanley","year":"2005","unstructured":"Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85(3):1093\u2013129.","journal-title":"Physiol Rev"},{"issue":"16","key":"811_CR13","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.jacc.2009.04.074","volume":"54","author":"LJ Rijzewijk","year":"2009","unstructured":"Rijzewijk LJ, van der Meer RW, Lamb HJ, de Jong HW, Lubberink M, Romijn JA, Bax JJ, de Roos A, Twisk JW, Heine RJ, et al. Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. J Am Coll Cardiol. 2009;54(16):1524\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"811_CR14","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jacc.2005.09.030","volume":"47","author":"P Herrero","year":"2006","unstructured":"Herrero P, Peterson LR, McGill JB, Matthew S, Lesniak D, Dence C, Gropler RJ. Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus. J Am Coll Cardiol. 2006;47(3):598\u2013604.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"811_CR15","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.jacc.2008.07.062","volume":"52","author":"LJ Rijzewijk","year":"2008","unstructured":"Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, Romijn JA, de Roos A, Lamb HJ. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol. 2008;52(22):1793\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"811_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215\u201333.","journal-title":"Cell"},{"issue":"1\u20132","key":"811_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11010-016-2729-7","volume":"417","author":"SK Raut","year":"2016","unstructured":"Raut SK, Singh GB, Rastogi B, Saikia UN, Mittal A, Dogra N, Singh S, Prasad R, Khullar M. miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy. Mol Cell Biochem. 2016;417(1\u20132):191\u2013203.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"811_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12933-018-0684-1","volume":"17","author":"N Ghosh","year":"2018","unstructured":"Ghosh N, Katare R. Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides. Cardiovasc Diabetol. 2018;17(1):43.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"811_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12933-018-0767-z","volume":"17","author":"B Dai","year":"2018","unstructured":"Dai B, Li H, Fan J, Zhao Y, Yin Z, Nie X, Wang DW, Chen C. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin. Cardiovasc Diabetol. 2018;17(1):123.","journal-title":"Cardiovasc Diabetol"},{"issue":"Database issue","key":"811_CR20","doi-asserted-by":"publisher","first-page":"D355","DOI":"10.1093\/nar\/gkp896","volume":"38","author":"M Kanehisa","year":"2010","unstructured":"Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010;38(Database issue):D355\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"811_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357.","journal-title":"Nat Protoc"},{"issue":"Database issue","key":"811_CR22","doi-asserted-by":"publisher","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","volume":"42","author":"A Kozomara","year":"2014","unstructured":"Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42(Database issue):D68\u201373.","journal-title":"Nucleic Acids Res"},{"key":"811_CR23","doi-asserted-by":"publisher","first-page":"e05005","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005.","journal-title":"Elife"},{"issue":"5","key":"811_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ng1536","volume":"37","author":"A Krek","year":"2005","unstructured":"Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37(5):495\u2013500.","journal-title":"Nat Genet"},{"issue":"Database issue","key":"811_CR25","doi-asserted-by":"publisher","first-page":"D153","DOI":"10.1093\/nar\/gku1215","volume":"43","author":"IS Vlachos","year":"2015","unstructured":"Vlachos IS, Paraskevopoulou MD, Karagkouni D, Georgakilas G, Vergoulis T, Kanellos I, Anastasopoulos IL, Maniou S, Karathanou K, Kalfakakou D, et al. DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions. Nucleic Acids Res. 2015;43(Database issue):D153\u20139.","journal-title":"Nucleic Acids Res."},{"issue":"Web Server issu","key":"811_CR26","doi-asserted-by":"publisher","first-page":"W451","DOI":"10.1093\/nar\/gkl243","volume":"34","author":"J Kruger","year":"2006","unstructured":"Kruger J, Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 2006;34(Web Server issue):W451\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"811_CR27","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1073\/pnas.95.8.4333","volume":"95","author":"JB Kim","year":"1998","unstructured":"Kim JB, Wright HM, Wright M, Spiegelman BM. ADD1\/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc Natl Acad Sci USA. 1998;95(8):4333\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"811_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/cvr\/cvu254","volume":"105","author":"M Yan","year":"2015","unstructured":"Yan M, Chen C, Gong W, Yin Z, Zhou L, Chaugai S, Wang DW. miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8. Cardiovasc Res. 2015;105(3):340\u201352.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"811_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000438607","volume":"38","author":"J Huang","year":"2016","unstructured":"Huang J, Meng Y, Liu Y, Chen Y, Yang H, Chen D, Shi J, Guo Y. MicroRNA-320a regulates the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting HOXA10. Cell Physiol Biochem. 2016;38(1):40\u20138.","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"811_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s11373-006-9076-8","volume":"13","author":"TH Huang","year":"2006","unstructured":"Huang TH, Li Y, Razmovski-Naumovski V, Tran VH, Li GQ, Duke CC, Roufogalis BD. Gypenoside XLIX isolated from Gynostemma pentaphyllum inhibits nuclear factor-kappaB activation via a PPAR-alpha-dependent pathway. J Biomed Sci. 2006;13(4):535\u201348.","journal-title":"J Biomed Sci"},{"issue":"1","key":"811_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","volume":"14","author":"K Inagaki","year":"2006","unstructured":"Inagaki K, Fuess S, Storm TA, Gibson GA, McTiernan CF, Kay MA, Nakai H. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol Ther. 2006;14(1):45\u201353.","journal-title":"Mol Ther"},{"issue":"9","key":"811_CR32","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1161\/CIRCULATIONAHA.114.012285","volume":"131","author":"F Liu","year":"2015","unstructured":"Liu F, Song R, Feng Y, Guo J, Chen Y, Zhang Y, Chen T, Wang Y, Huang Y, Li CY, et al. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor alpha. Circulation. 2015;131(9):795\u2013804.","journal-title":"Circulation"},{"key":"811_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.omtn.2017.03.005","volume":"7","author":"C Chen","year":"2017","unstructured":"Chen C, Yang S, Li H, Yin Z, Fan J, Zhao Y, Gong W, Yan M, Wang DW. Mir30c is involved in diabetic cardiomyopathy through regulation of cardiac autophagy via BECN1. Mol Ther Nucleic Acids. 2017;7:127\u201339.","journal-title":"Mol Ther Nucleic Acids"},{"key":"811_CR34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.yjmcc.2012.06.008","volume":"55","author":"PA Crawford","year":"2013","unstructured":"Crawford PA, Schaffer JE. Metabolic stress in the myocardium: adaptations of gene expression. J Mol Cell Cardiol. 2013;55:130\u20138.","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"811_CR35","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/nm.3200","volume":"19","author":"J Soh","year":"2013","unstructured":"Soh J, Iqbal J, Queiroz J, Fernandez-Hernando C, Hussain MM. MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Nat Med. 2013;19(7):892\u2013900.","journal-title":"Nat Med"},{"issue":"3","key":"811_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/1755-5922.12113","volume":"33","author":"SK Raut","year":"2015","unstructured":"Raut SK, Kumar A, Singh GB, Nahar U, Sharma V, Mittal A, Sharma R, Khullar M. miR-30c mediates upregulation of Cdc42 and Pak1 in diabetic cardiomyopathy. Cardiovasc Ther. 2015;33(3):89\u201397.","journal-title":"Cardiovasc Ther"},{"issue":"12","key":"811_CR37","first-page":"4284","volume":"83","author":"RA Phillips","year":"1998","unstructured":"Phillips RA, Krakoff LR, Dunaif A, Finegood DT, Gorlin R, Shimabukuro S. Relation among left ventricular mass, insulin resistance, and blood pressure in nonobese subjects. J Clin Endocrinol Metab. 1998;83(12):4284\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"811_CR38","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122(4):624\u201338.","journal-title":"Circ Res"},{"issue":"9\u201310","key":"811_CR39","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1242\/dmm.001941","volume":"2","author":"H Bugger","year":"2009","unstructured":"Bugger H, Abel ED. Rodent models of diabetic cardiomyopathy. Dis Model Mech. 2009;2(9\u201310):454\u201366.","journal-title":"Dis Model Mech"},{"issue":"1","key":"811_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1172\/JCI0214080","volume":"109","author":"BN Finck","year":"2002","unstructured":"Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest. 2002;109(1):121\u201330.","journal-title":"J Clin Invest"},{"issue":"6","key":"811_CR41","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1074\/jbc.M106054200","volume":"277","author":"FM Campbell","year":"2002","unstructured":"Campbell FM, Kozak R, Wagner A, Altarejos JY, Dyck JR, Belke DD, Severson DL, Kelly DP, Lopaschuk GD. A role for peroxisome proliferator-activated receptor alpha (PPARalpha) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase. J Biol Chem. 2002;277(6):4098\u2013103.","journal-title":"J Biol Chem"},{"issue":"1","key":"811_CR42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-017-0602-y","volume":"16","author":"JC Fruchart","year":"2017","unstructured":"Fruchart JC. Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia. Cardiovasc Diabetol. 2017;16(1):124.","journal-title":"Cardiovasc Diabetol"},{"key":"811_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12763","author":"L Wu","year":"2018","unstructured":"Wu L, Wang K, Wang W, Wen Z, Wang P, Liu L, Wang DW. Glucagon-like peptide-1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPARalpha pathway. Aging Cell. 2018. \n                    https:\/\/doi.org\/10.1111\/acel.12763\n                    \n                  .","journal-title":"Aging Cell"},{"issue":"4","key":"811_CR44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.tcm.2012.07.003","volume":"22","author":"C Riehle","year":"2012","unstructured":"Riehle C, Abel ED. PGC-1 proteins and heart failure. Trends Cardiovasc Med. 2012;22(4):98\u2013105.","journal-title":"Trends Cardiovasc Med"},{"key":"811_CR45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.mce.2016.04.004","volume":"430","author":"J Lasheras","year":"2016","unstructured":"Lasheras J, Vila M, Zamora M, Riu E, Pardo R, Poncelas M, Cases I, Ruiz-Meana M, Hernandez C, Feliu JE, et al. Gene expression profiling in hearts of diabetic mice uncovers a potential role of estrogen-related receptor gamma in diabetic cardiomyopathy. Mol Cell Endocrinol. 2016;430:77\u201388.","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"811_CR46","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1172\/JCI10268","volume":"106","author":"JJ Lehman","year":"2000","unstructured":"Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest. 2000;106(7):847\u201356.","journal-title":"J Clin Invest"},{"issue":"7","key":"811_CR47","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/CIRCRESAHA.110.223818","volume":"107","author":"GC Rowe","year":"2010","unstructured":"Rowe GC, Jiang A, Arany Z. PGC-1 coactivators in cardiac development and disease. Circ Res. 2010;107(7):825\u201338.","journal-title":"Circ Res"},{"issue":"2","key":"811_CR48","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.expneurol.2012.06.031","volume":"237","author":"A Camacho","year":"2012","unstructured":"Camacho A, Rodriguez-Cuenca S, Blount M, Prieur X, Barbarroja N, Fuller M, Hardingham GE, Vidal-Puig A. Ablation of PGC1 beta prevents mTOR dependent endoplasmic reticulum stress response. Exp Neurol. 2012;237(2):396\u2013406.","journal-title":"Exp Neurol"},{"key":"811_CR49","doi-asserted-by":"publisher","first-page":"21565","DOI":"10.1038\/srep21565","volume":"6","author":"L Jiang","year":"2016","unstructured":"Jiang L, Zang D, Yi S, Li X, Yang C, Dong X, Zhao C, Lan X, Chen X, Liu S, et al. A microRNA-mediated decrease in eukaryotic initiation factor 2alpha promotes cell survival during PS-341 treatment. Sci Rep. 2016;6:21565.","journal-title":"Sci Rep"},{"issue":"2","key":"811_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.bbadis.2014.05.006","volume":"1852","author":"L Yang","year":"2015","unstructured":"Yang L, Zhao D, Ren J, Yang J. Endoplasmic reticulum stress and protein quality control in diabetic cardiomyopathy. Biochim Biophys Acta. 2015;1852(2):209\u201318.","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"811_CR51","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.2337\/diabetes.54.9.2514","volume":"54","author":"SY Park","year":"2005","unstructured":"Park SY, Cho YR, Finck BN, Kim HJ, Higashimori T, Hong EG, Lee MK, Danton C, Deshmukh S, Cline GW, et al. Cardiac-specific overexpression of peroxisome proliferator-activated receptor-alpha causes insulin resistance in heart and liver. Diabetes. 2005;54(9):2514\u201324.","journal-title":"Diabetes"},{"key":"811_CR52","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12933-014-0118-7","volume":"13","author":"C Marciniak","year":"2014","unstructured":"Marciniak C, Marechal X, Montaigne D, Neviere R, Lancel S. Cardiac contractile function and mitochondrial respiration in diabetes-related mouse models. Cardiovasc Diabetol. 2014;13:118.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"811_CR53","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1074\/jbc.M113.523654","volume":"289","author":"L Lai","year":"2014","unstructured":"Lai L, Wang M, Martin OJ, Leone TC, Vega RB, Han X, Kelly DP. A role for peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1) in the regulation of cardiac mitochondrial phospholipid biosynthesis. J Biol Chem. 2014;289(4):2250\u20139.","journal-title":"J Biol Chem"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0811-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-019-0811-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0811-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T19:10:43Z","timestamp":1578683443000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-019-0811-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,11]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["811"],"URL":"https:\/\/doi.org\/10.1186\/s12933-019-0811-7","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,11]]},"assertion":[{"value":"20 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"7"}}